Department of Neurology, Beth Israel Deaconess Medical Center, Center for Life Sciences, 330 Brookline Ave, Boston, MA 02215, USA.
Neuromolecular Med. 2010 Jun;12(2):149-63. doi: 10.1007/s12017-009-8094-x. Epub 2009 Oct 14.
Neurologic disease promoted by microbial pathogens, sterile injury, or neurodegeneration rapidly induces innate immunity in adjacent healthy tissue, which in turn contributes extensively to neurologic injury. With more recent focus on innate immune processes, it appears that necrotic, but not apoptotic, death mechanisms provoke inflammatory responses likely due to the release or production of endogenous ligands that activate resident immune cells of the central nervous system. These ligands comprise a diverse set of proteins, nucleic acids, and glycosaminoglycans, including heat shock proteins, HMGB1, RNA, DNA, hyaluronan, and heparin sulfate, that stimulate innate immune mechanisms largely through Toll-like receptors (TLRs). The blockade of interactions between endogenous ligands and TLRs may enable neuroprotective therapeutic strategies for a variety of neurologic diseases.
微生物病原体、非感染性损伤或神经退行性病变引起的神经疾病会迅速在邻近的健康组织中引发固有免疫,而固有免疫反过来又会极大地促进神经损伤。随着人们对固有免疫过程的关注不断增加,似乎坏死(而非凋亡)死亡机制会引发炎症反应,这可能是由于释放或产生了激活中枢神经系统固有免疫细胞的内源性配体。这些配体包括一组多样化的蛋白质、核酸和糖胺聚糖,如热休克蛋白、高迁移率族蛋白 B1、RNA、DNA、透明质酸和肝素硫酸盐,它们主要通过 Toll 样受体 (TLR) 刺激固有免疫机制。阻断内源性配体与 TLR 之间的相互作用可能为多种神经疾病提供神经保护治疗策略。